We took some time to sit down and talk with Dr Sales so you could get to know him a bit better......
23
Feb
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods...
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug dis...
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services....
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The...
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the...
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bi...
作为 Healius 网络的一部分，Agilex Biolabs 公司继续进行全球扩张和企业发展，斯蒂芬-麦金太尔（Stephen McIntyre）被选为公司首席执行官。
ddPCR technology provides an opportunity to streamline research and development processes, saving ti...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agil...
